Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Route of Administration Outlook
3.3. Anticoagulant Drug Outlook
3.4. Drug Class Outlook
3.5. Application Outlook
3.6. Geography Outlook
3.7. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of venous thromboembolism and cardiovascular disorders
5.2.2. Growing number of elderly and obese people
5.2.3. Increasing acceptance of novel oral anticoagulants
5.3. Restraints
5.3.1. Stringent regulations related to drug dosage and clinical approvals
5.4. Opportunities
5.4.1. Introduction of novel anticoagulation therapeutics and increasing R&D investments
5.4.2. Increasing collaboration activities and development of generic drugs
5.5. Challenges
5.5.1. Potential risk associated with the side-effects and complications associated with the usage of oral anticoagulants


6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations


7. Global Anticoagulant Market, By Route of Administration
7.1. Introduction
7.2. Injectable Anticoagulants
7.3. Oral Anticoagulants


8. Global Anticoagulant Market, By Anticoagulant Drug
8.1. Introduction
8.2. Betrixaban
8.3. Dabigatran
8.4. Edoxaban / Rivaroxaban
8.5. Eliquis


9. Global Anticoagulant Market, By Drug Class
9.1. Introduction
9.2. DTIs
9.3. Factor XA Inhibitors
9.4. Heparin
9.5. Vitamin K Antagonists


10. Global Anticoagulant Market, By Application
10.1. Introduction
10.2. Atrial fibrillation & Heart Attack
10.3. Deep Vein Thrombosis
10.4. Pulmonary Embolism
10.5. Stroke


11. Global Anticoagulant Market, By Geography
11.1. Introduction
11.2. Americas
11.2.1. Argentina
11.2.2. Brazil
11.2.3. Canada
11.2.4. Mexico
11.2.5. United States
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Indonesia
11.3.5. Japan
11.3.6. Malaysia
11.3.7. Philippines
11.3.8. South Korea
11.3.9. Thailand
11.4. Europe, Middle East & Africa
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Netherlands
11.4.5. Qatar
11.4.6. Russia
11.4.7. Saudi Arabia
11.4.8. South Africa
11.4.9. Spain
11.4.10. United Arab Emirates
11.4.11. United Kingdom


12. 360iResearch Competitive Strategic Window
12.1. Introduction
12.2. 360iResearch Competitive Strategic Window, by Route of Administration
12.3. 360iResearch Competitive Strategic Window, by Anticoagulant Drug
12.4. 360iResearch Competitive Strategic Window, by Drug Class
12.5. 360iResearch Competitive Strategic Window, by Application
12.6. 360iResearch Competitive Strategic Window, by Geography


13. Competitive Landscape
13.1. 360iResearch FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. 360iResearch Market Ranking Analysis
13.3. 360iResearch Market Share Analysis
13.4. 360iResearch Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion


14. Company Usability Profiles
14.1. Akebia Therapeutics, Inc.
14.2. Aspen Pharmacare Holdings Limited
14.3. AstraZeneca PLC
14.4. Athenex, Inc.
14.5. Baxter Laboratories Pty Ltd.
14.6. Bayer AG
14.7. C.H. Boehringer Sohn AG & Ko. KG
14.8. Eli Lilly and Company
14.9. Johnson & Johnson
14.10. Mylan N.V.
14.11. Novartis AG
14.12. Pfizer Inc.
14.13. Sandoz International GmbH
14.14. Sanofi S.A.
14.15. Teva Pharmaceutical Industries Ltd.


15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details



List of Figures



FIGURE 1. GLOBAL ANTICOAGULANT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTICOAGULANT MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTICOAGULANT MARKET, BY TYPE
FIGURE 10. GLOBAL ANTICOAGULANT MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 11. GLOBAL ANTICOAGULANT MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 12. GLOBAL ANTICOAGULANT MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ANTICOAGULANT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2019 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2025
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2025
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 28. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS


List of Tables



TABLE 1. GLOBAL ANTICOAGULANT MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 22. AMERICAS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 23. AMERICAS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 24. AMERICAS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 25. AMERICAS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 26. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 27. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 28. ARGENTINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 29. ARGENTINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 30. BRAZIL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 31. BRAZIL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 32. BRAZIL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 33. BRAZIL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 34. CANADA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 35. CANADA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 36. CANADA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 37. CANADA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 38. MEXICO ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 39. MEXICO ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 40. MEXICO ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 41. MEXICO ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 42. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 43. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 44. UNITED STATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 45. UNITED STATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 46. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 47. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 48. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 50. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 51. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 52. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 53. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 54. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 55. CHINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 56. CHINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 57. CHINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 58. CHINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 59. INDIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 60. INDIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 61. INDIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 62. INDIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 63. INDONESIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 64. INDONESIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 65. INDONESIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 66. INDONESIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 67. JAPAN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 68. JAPAN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 69. JAPAN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 70. JAPAN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 71. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 72. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 73. MALAYSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 74. MALAYSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 75. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 76. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 77. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 78. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 79. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 80. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 81. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 82. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 83. THAILAND ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 84. THAILAND ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 85. THAILAND ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 86. THAILAND ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 92. FRANCE ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 93. FRANCE ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 94. FRANCE ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 95. FRANCE ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 96. GERMANY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 97. GERMANY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 98. GERMANY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 99. GERMANY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 100. ITALY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 101. ITALY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 102. ITALY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 103. ITALY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 104. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 105. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 106. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 107. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 108. QATAR ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 109. QATAR ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 110. QATAR ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 111. QATAR ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 112. RUSSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 113. RUSSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 114. RUSSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 115. RUSSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 116. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 117. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 118. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 119. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 120. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 121. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 122. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 123. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 124. SPAIN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 125. SPAIN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 126. SPAIN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 127. SPAIN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 132. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2025 (USD MILLION)
TABLE 133. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2017-2025 (USD MILLION)
TABLE 134. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 135. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
TABLE 136. GLOBAL ANTICOAGULANT MARKET: SCORES
TABLE 137. GLOBAL ANTICOAGULANT MARKET: BUSINESS STRATEGY
TABLE 138. GLOBAL ANTICOAGULANT MARKET: PRODUCT SATISFACTION
TABLE 139. GLOBAL ANTICOAGULANT MARKET: RANKING
TABLE 140. GLOBAL ANTICOAGULANT MARKET: MERGER & ACQUISITION
TABLE 141. GLOBAL ANTICOAGULANT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 142. GLOBAL ANTICOAGULANT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 143. GLOBAL ANTICOAGULANT MARKET: INVESTMENT & FUNDING
TABLE 144. GLOBAL ANTICOAGULANT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 145. GLOBAL ANTICOAGULANT MARKET: EDITION DETAILS
TABLE 146. GLOBAL ANTICOAGULANT MARKET: LICENSE DETAILS
TABLE 147. GLOBAL ANTICOAGULANT MARKET: PRICING DETAILS